As Expected, Orchid BioSciences Changes Name to Orchid Cellmark

genomeweb
360dx

As Expected, Orchid BioSciences Changes Name to Orchid Cellmark

Jun 09, 2005

NEW YORK, June 9 (GenomeWeb News) - Orchid BioSciences will change its name to Orchid Cellmark to reflect what the company said is its new emphasis on DNA-based identity testing, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Acute Myeloid Leukemia Analysis Brings Together Integrated 'Omic, Drug Response Profiles
Foundation Medicine, Novartis Partner to Develop CDx for Oncology Drugs
Roche Diagnostics' Revenues Grow 6 Percent in First Nine Months of 2018
Abbott Q3 Dx Business Grows 43 Percent
Arcis Biotechnology, Teleflex Sign License Agreement
Thermo Fisher Scientific Gets CE-IVD Mark for NGS Cancer Test

The Scan

Microsoft, But the Brain, Too

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

Been Reclassified

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

Pursuit of a Cancer Vaccine

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

This Week in Cell

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

Main menu